Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer

Journal of Ovarian Research

Volumn 5, Issue 1, 2012, Pages

  Mosig, Rebecca A ^a   Lin, Li ^a   Senturk, Emir ^a   Shah, Hardik ^a   Huang, Fei ^a   Schlosshauer, Peter ^a   Cohen, Samantha ^a   Fruscio, Robert ^b   Marchini, Sergio ^c   D'Incalci, Maurizio ^c   Sachidanandam, Ravi ^a   Dottino, Peter ^a   Martignetti, John A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SAN GERARDO HOSPITAL   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

CD151; Epithelial Ovarian Cancer; Invasion; Metastasis; Migration; RNA Seq

Indexed keywords

ANTIBODY; CD151 ANTIGEN; MESSENGER RNA; PROTEIN; RNA; SMALL INTERFERING RNA; TRANSCRIPTOME;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CELL INVASION; CELL JUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; EPITHELIAL OVARIAN CANCER; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE TARGETING; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MEDIATOR; METASTASIS; OVARIECTOMY; OVARY; OVARY CANCER; OVARY EPITHELIAL CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; TRANSCRIPTOMICS;

EID: 84856070338     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-5-4     Document Type: Article

References (36)

1. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK, SEER Cancer Statistics Review, 1975-2007 [Internet] Bethesda, MD: National Cancer Institute
2. Cancer of the ovary. Cannistra SA, N Engl J Med 2004 351 2519 29 10.1056/NEJMra041842 15590954 (Pubitemid 39603165)
3. Achievements and unmet needs in the management of advanced ovarian cancer. Guarneri V, Piacentini F, Barbieri E, Conte PF, Gynecol Oncol 2010 117 152 8 10.1016/j.ygyno.2009.11.033 20056266
4. A small-cell lung cancer genome with complex signatures of tobacco exposure. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, Varela I, Nik-Zainal S, Davies HR, Ordonez GR, Mudie LJ, Latimer C, Edkins S, Stebbings L, Chen L, Jia M, Leroy C, Marshall J, Menzies A, Butler A, Teague JW, Mangion J, Sun YA, McLaughlin SF, Peckham HE, Tsung EF, Costa GL, Lee CC, Minna JD, Gazdar A, Birney E, Rhodes MD, McKernan KJ, Stratton MR, Futreal PA, Campbell PJ, Nature 2010 463 184 90 10.1038/nature08629 20016488
5. Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis. Timmermann B, Kerick M, Roehr C, Fischer A, Isau M, Boerno ST, Wunderlich A, Barmeyer C, Seemann P, Koenig J, Lappe M, Kuss AW, Garshasbi M, Bertram L, Trappe K, Werber M, Herrmann BG, Zatloukal K, Lehrach H, Schweiger MR, PLoS One 2010 5 15661 10.1371/journal.pone.0015661 21203531
6. A comprehensive catalogue of somatic mutations from a human cancer genome. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordonez GR, Bignell GR, Ye K, Alipaz J, Bauer MJ, Beare D, Butler A, Carter RJ, Chen L, Cox AJ, Edkins S, Kokko-Gonzales PI, Gormley NA, Grocock RJ, Haudenschild CD, Hims MM, James T, Jia M, Kingsbury Z, Leroy C, Marshall J, Menzies A, Mudie LJ, Ning Z, Royce T, Schulz-Trieglaff OB, Spiridou A, Stebbings LA, Szajkowski L, Teague J, Williamson D, Chin L, Ross MT, Campbell PJ, Bentley DR, Futreal PA, Stratton MR, Nature 2010 463 191 6 10.1038/nature08658 20016485
7. Signatures of mutation and selection in the cancer genome. Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, Buck G, Chen L, Beare D, Latimer C, Widaa S, Hinton J, Fahey C, Fu B, Swamy S, Dalgliesh GL, Teh BT, Deloukas P, Yang F, Campbell PJ, Futreal PA, Stratton MR, Nature 2010 463 893 8 10.1038/nature08768 20164919
8. CD151 dynamics in carcinoma-stroma interaction: Integrin expression, adhesion strength and proteolytic activity. Hasegawa M, Furuya M, Kasuya Y, Nishiyama M, Sugiura T, Nikaido T, Momota Y, Ichinose M, Kimura S, Lab Invest 2007 87 882 92 10.1038/labinvest.3700657 17632541 (Pubitemid 47267817)
9. Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. Liu L, He B, Liu WM, Zhou D, Cox JV, Zhang XA, J Biol Chem 2007 282 31631 42 10.1074/jbc.M701165200 17716972 (Pubitemid 350044885)
10. Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. Yang XH, Flores LM, Li Q, Zhou P, Xu F, Krop IE, Hemler ME, Cancer Res 2010 70 2256 63 10.1158/0008-5472.CAN-09-4032 20197472
11. CD151 gene delivery after myocardial infarction promotes functional neovascularization and activates FAK signaling. Zuo H, Liu Z, Liu X, Yang J, Liu T, Wen S, Zhang XA, Cianflone K, Wang D, Mol Med 2009 15 307 15 19603100
12. CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Yang XH, Richardson AL, Torres-Arzayus MI, Zhou P, Sharma C, Kazarov AR, Andzelm MM, Strominger JL, Brown M, Hemler ME, Cancer Res 2008 68 3204 13 10.1158/0008-5472.CAN-07-2949 18451146
13. The tetraspanin CD151 functions as a negative regulator in the adhesion-dependent activation of ras. Sawada S, Yoshimoto M, Odintsova E, Hotchin NA, Berditchevski F, J Biol Chem 2003 278 26323 6 10.1074/jbc.C300210200 12782641 (Pubitemid 36876769)
14. The tetraspanin CD151 is required for met-dependent signaling and tumor cell growth. Franco M, Muratori C, Corso S, Tenaglia E, Bertotti A, Capparuccia L, Trusolino L, Comoglio PM, Tamagnone L, J Biol Chem 2010
15. Expression and prognostic significance of CD151, c-met, and integrin alpha3/alpha6 in pancreatic ductal adenocarcinoma. Zhu GH, Huang C, Qiu ZJ, Liu J, Zhang ZH, Zhao N, Feng ZZ, Lv XH, Dig Dis Sci 2010
16. Tetraspanin CD151 regulates RhoA activation and the dynamic stability of carcinoma cell-cell contacts. Johnson JL, Winterwood N, DeMali KA, Stipp CS, J Cell Sci 2009 122 2263 73 10.1242/jcs.045997 19509057
17. Role of overexpression of CD151 and/or c-met in predicting prognosis of hepatocellular carcinoma. Ke AW, Shi GM, Zhou J, Wu FZ, Ding ZB, Hu MY, Xu Y, Song ZJ, Wang ZJ, Wu JC, Bai DS, Li JC, Liu KD, Fan J, Hepatology 2009 49 491 503 10.1002/hep.22639 19065669
18. The tetraspanin CD151 regulates cell morphology and intracellular signaling on laminin-511. Yamada M, Sumida Y, Fujibayashi A, Fukaguchi K, Sanzen N, Nishiuchi R, Sekiguchi K, FEBS J 2008 275 3335 51 10.1111/j.1742-4658.2008. 06481.x 18492066 (Pubitemid 351813546)
19. The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Zijlstra A, Lewis J, Degryse B, Stuhlmann H, Quigley JP, Cancer Cell 2008 13 221 34 10.1016/j.ccr.2008.01.031 18328426 (Pubitemid 351318371)
20. Analysis of gene expression in early-stage ovarian cancer. Marchini S, Mariani P, Chiorino G, Marrazzo E, Bonomi R, Fruscio R, Clivio L, Garbi A, Torri V, Cinquini M, Dell'Anna T, Apolone G, Broggini M, D'Incalci M, Clin Cancer Res 2008 14 7850 60 10.1158/1078-0432.CCR-08-0523 19047114
21. Mapping and quantifying mammalian transcriptomes by RNA-seq. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, Nat Methods 2008 5 621 8 10.1038/nmeth.1226 18516045 (Pubitemid 351911867)
22. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Mosig RA, Dowling O, Difeo A, Ramirez MC, Parker IC, Abe E, Diouri J, Aqeel AA, Wylie JD, Oblander SA, Madri J, Bianco P, Apte SS, Zaidi M, Doty SB, Majeska RJ, Schaffler MB, Martignetti JA, Hum Mol Genet 2007 16 1113 23 10.1093/hmg/ddm060 17400654 (Pubitemid 47062731)
23. Quantitative real-time reverse transcription polymerase chain reaction: Normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Tricarico C, Pinzani P, Bianchi S, Paglierani M, Distante V, Pazzagli M, Bustin SA, Orlando C, Anal Biochem 2002 309 293 300 10.1016/S0003-2697(02)00311-1 12413463 (Pubitemid 35387321)
24. The single subunit transmembrane E3 ligase gene related to anergy in lymphocytes (GRAIL) captures and then ubiquitinates transmembrane proteins across the cell membrane. Lineberry N, Su L, Soares L, Fathman CG, J Biol Chem 2008 283 28497 505 10.1074/jbc.M805092200 18713730
25. Activation-induced internalization differs for the tetraspanins CD9 and Tspan8: Impact on tumor cell motility. Rana S, Claas C, Kretz CC, Zoeller M, Int J Biochem Cell Biol 2010
26. Palmitoylation of tetraspanin proteins: Modulation of CD151 lateral interactions, subcellular distribution, and integrin-dependent cell morphology. Yang X, Claas C, Kraeft SK, Chen LB, Wang Z, Kreidberg JA, Hemler ME, Mol Biol Cell 2002 13 767 81 10.1091/mbc.01-05-0275 11907260 (Pubitemid 34250345)
27. CD151 regulates HGF-stimulated morphogenesis of human breast cancer cells. Klosek SK, Nakashiro K, Hara S, Goda H, Hasegawa H, Hamakawa H, Biochem Biophys Res Commun 2009 379 1097 100 10.1016/j.bbrc.2009.01.023 19159612
28. Regulation of CD151 by hypoxia controls cell adhesion and metastasis in colorectal cancer. Chien CW, Lin SC, Lai YY, Lin BW, Lin SC, Lee JC, Tsai SJ, Clin Cancer Res 2008 14 8043 51 10.1158/1078-0432.CCR-08-1651 19073968
29. Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells. Sauer G, Kurzeder C, Grundmann R, Kreienberg R, Zeillinger R, Deissler H, Oncol Rep 2003 10 405 10 12579280
30. DHHC2 affects palmitoylation, stability, and functions of tetraspanins CD9 and CD151. Sharma C, Yang XH, Hemler ME, Mol Biol Cell 2008 19 3415 25 10.1091/mbc.E07-11-1164 18508921
31. CD151 regulates epithelial cell-cell adhesion through PKC- and Cdc42-dependent actin cytoskeletal reorganization. Shigeta M, Sanzen N, Ozawa M, Gu J, Hasegawa H, Sekiguchi K, J Cell Biol 2003 163 165 76 10.1083/jcb. 200301075 14557253 (Pubitemid 37271443)
32. Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Testa JE, Brooks PC, Lin JM, Quigley JP, Cancer Res 1999 59 3812 20 10447000 (Pubitemid 29381891)
33. CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Sadej R, Romanska H, Baldwin G, Gkirtzimanaki K, Novitskaya V, Filer AD, Krcova Z, Kusinska R, Ehrmann J, Buckley CD, Kordek R, Potemski P, Eliopoulos AG, Lalani e, Berditchevski F, Mol Cancer Res 2009 7 787 98 10.1158/1541-7786.MCR-08-0574 19531562
34. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: Impact on cell motility. Gesierich S, Paret C, Hildebrand D, Weitz J, Zgraggen K, Schmitz-Winnenthal FH, Horejsi V, Yoshie O, Herlyn D, Ashman LK, Zoller M, Clin Cancer Res 2005 11 2840 52 10.1158/1078-0432.CCR-04-1935 15837731 (Pubitemid 40525182)
35. Expression of tetraspanins in human lung cancer cells: Frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer. Funakoshi T, Tachibana I, Hoshida Y, Kimura H, Takeda Y, Kijima T, Nishino K, Goto H, Yoneda T, Kumagai T, Osaki T, Hayashi S, Aozasa K, Kawase I, Oncogene 2003 22 674 87 10.1038/sj.onc.1206106 12569360 (Pubitemid 36269281)
36. Clinical significance of CD151 gene expression in non-small cell lung cancer. Tokuhara T, Hasegawa H, Hattori N, Ishida H, Taki T, Tachibana S, Sasaki S, Miyake M, Clin Cancer Res 2001 7 4109 14 11751509 (Pubitemid 34044635)